IGHE and laryngotracheoesophageal cleft: And then, we performed the comprehensive evaluation of the diagnostic performances of anti-TIF1γ-IgA, IgG, IgM, and IgE in a cohort of up to 666 serum samples of 248 patients with LC at early stage, 200 patients with LBL, and 218 HC.